Clinical Trial Update: Metformin and Nightly Fasting in Women With Early Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating metformin combined with nightly fasting in women with early breast cancer. The study, sponsored by MD Anderson Cancer C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ
• Invasive Breast Carcinoma

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING